Cargando…
Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome
Mevalonic aciduria (MVA) and hyperimmunoglobulinemia D syndrome (HIDS) represent the two ends of a clinical spectrum of disease caused by deficiency of mevalonate kinase (MVK), the first committed enzyme of cholesterol biosynthesis. At least 30 patients with MVA and 180 patients with HIDS have been...
Autores principales: | Haas, Dorothea, Hoffmann, Georg F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1475558/ https://www.ncbi.nlm.nih.gov/pubmed/16722536 http://dx.doi.org/10.1186/1750-1172-1-13 |
Ejemplares similares
-
Mevalonate kinase deficiency: current perspectives
por: Favier, Leslie A, et al.
Publicado: (2016) -
Diagnostic value of urinary mevalonic acid excretion in mevalonate kinase deficiency (MKD)
por: Jeyaratnam, Jerold, et al.
Publicado: (2014) -
Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?
por: Mulders-Manders, C. M., et al.
Publicado: (2015) -
Mevalonate kinase somatic mosaicism and bigenic genotypes may explain heterogeneity in mevalonate kinase deficiency
por: Shinar, Y, et al.
Publicado: (2015) -
Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
por: Rafiq, Nadia K., et al.
Publicado: (2018)